Schedule 13G ownership disclosure

DelMar Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 247078306

Event date: 2019-06-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
292,500
Percent of class
7.6500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-19-002623
Form type
SC 13G
Filer
TuHURA Biosciences, Inc./NV
CIK
CIK 1498382
Filed
Jun 05, 2019
Reporting period
Jun 03, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub